Integrating splice-isoform expression into genome-scale models characterizes breast cancer metabolism

    Research output: Contribution to journalArticlepeer-review

    226 Downloads (Pure)


    Motivation: Despite being often perceived as the main contributors to cell fate and physiology, genes alone cannot predict cellular phenotype. During the process of gene expression, 95% of human genes can code for multiple proteins due to alternative splicing. While most splice variants of a gene carry the same function, variants within some key genes can have remarkably different roles. To bridge the gap between genotype and phenotype, condition- and tissue-specific models of metabolism have been constructed. However, current metabolic models only include information at the gene level. Consequently, as recently acknowledged by the scientific community, common situations where changes in splice-isoformexpression levels alter the metabolic outcome cannot be modeled. Results: We here propose GEMsplice, the first method for the incorporation of splice-isoform expression data into genome-scale metabolic models. Using GEMsplice, we make full use of RNA-Seq quantitative expression profiles to predict, for the first time, the effects of splice isoform-level changes in the metabolism of 1455 patients with 31 different breast cancer types. We validate GEMsplice by generating cancerversus- normal predictions on metabolic pathways, and by comparing with gene-level approaches and available literature on pathways affected by breast cancer. GEMsplice is freely available for academic use at Compared to state-of-the-art methods, we anticipate that GEMsplice will enable for the first time computational analyses at transcript level with splice-isoform resolution.
    Original languageEnglish
    Pages (from-to)494–501
    Number of pages8
    Issue number3
    Early online date8 Sept 2017
    Publication statusPublished - 1 Feb 2018


    Dive into the research topics of 'Integrating splice-isoform expression into genome-scale models characterizes breast cancer metabolism'. Together they form a unique fingerprint.

    Cite this